Apomorphine induced cognitive changes in Parkinson's disease

42Citations
Citations of this article
44Readers
Mendeley users who have this article in their library.

Abstract

Auditory event related potentials (ERPs) and visual evoked potentials (VEPs) were recorded from eight patients with Parkinson's disease, before and after a single dose of apomorphine. To assess the treatment effects, the patients' motor state, Benton visual retention test (BVRT), and digit span tests were also examined. After apomorphine, although motor performance improved, the ERP latencies were delayed and the N2-P3 ERP amplitude was significantly diminished by comparison with pretreatment values. These data suggest that apomorphine induces, besides its motor effects in patients with Parkinson's disease, a slowing down of cognitive processing. Preferential stimulation of dopamine autoreceptors in mesocortical andmesolimbic systems may represent a neural mechanism for these effects. Also, the posttreatment BVRT rotation errors significantly increased, suggesting an apomorphine induced impairment of visuospatial perception.

Cite

CITATION STYLE

APA

Růžička, E., Roth, J., Špačková, N., Mečíř, P., & Jech, R. (1994). Apomorphine induced cognitive changes in Parkinson’s disease. Journal of Neurology, Neurosurgery and Psychiatry, 57(8), 998–1001. https://doi.org/10.1136/jnnp.57.8.998

Register to see more suggestions

Mendeley helps you to discover research relevant for your work.

Already have an account?

Save time finding and organizing research with Mendeley

Sign up for free